• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫原性细胞死亡诱导的氟化破坏线粒体的螺旋多肽与 PD-L1 免疫检查点阻断协同作用。

Immunogenic Cell Death Inducing Fluorinated Mitochondria-Disrupting Helical Polypeptide Synergizes with PD-L1 Immune Checkpoint Blockade.

机构信息

Department of Chemical and Biomolecular Engineering Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Republic of Korea.

Department of Bioengineering, College of Engineering Hanyang University Seoul 04763 Republic of Korea.

出版信息

Adv Sci (Weinh). 2021 Feb 1;8(7):2001308. doi: 10.1002/advs.202001308. eCollection 2021 Apr.

DOI:10.1002/advs.202001308
PMID:33854870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8025002/
Abstract

Immunogenic cell death (ICD) is distinguished by the release of tumor-associated antigens (TAAs) and danger-associated molecular patterns (DAMPs). This cell death has been studied in the field of cancer immunotherapy due to the ability of ICD to induce antitumor immunity. Herein, endoplasmic reticulum (ER) stress-mediated ICD inducing fluorinated mitochondria-disrupting helical polypeptides (MDHPs) are reported. The fluorination of the polypeptide provides a high helical structure and potent anticancer ability. This helical polypeptide destabilizes the mitochondrial outer membrane, leading to the overproduction of intracellular reactive oxygen species (ROS) and apoptosis. In addition, this oxidative stress triggers ER stress-mediated ICD. The in vivo results show that cotreatment of fluorinated MDHP and antiprogrammed death-ligand 1 antibodies (PD-L1) significantly regresses tumor growth and prevents metastasis to the lungs by activating the cytotoxic T cell response and alleviating the immunosuppressive tumor microenvironment. These results indicate that fluorinated MDHP synergizes with the immune checkpoint blockade therapy to eliminate established tumors and to elicit antitumor immune responses.

摘要

免疫原性细胞死亡(ICD)的特征是释放肿瘤相关抗原(TAA)和危险相关分子模式(DAMP)。由于 ICD 能够诱导抗肿瘤免疫,因此在癌症免疫治疗领域对其进行了研究。本文报道了内质网(ER)应激介导的 ICD 诱导的氟化线粒体破坏螺旋多肽(MDHPs)。多肽的氟化提供了高螺旋结构和强大的抗癌能力。这种螺旋多肽破坏了线粒体的外膜,导致细胞内活性氧(ROS)的过度产生和细胞凋亡。此外,这种氧化应激会引发 ER 应激介导的 ICD。体内结果表明,氟化 MDHP 与抗程序性死亡配体 1 抗体(PD-L1)联合治疗可通过激活细胞毒性 T 细胞反应和减轻免疫抑制性肿瘤微环境,显著抑制肿瘤生长并防止转移到肺部。这些结果表明,氟化 MDHP 与免疫检查点阻断疗法协同作用,以消除已建立的肿瘤并引发抗肿瘤免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/554f71a8720e/ADVS-8-2001308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/4364cdb85de0/ADVS-8-2001308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/67b46c636b23/ADVS-8-2001308-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/4f0b33382ab5/ADVS-8-2001308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/ecd0936b8626/ADVS-8-2001308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/0cdac03da573/ADVS-8-2001308-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/e7d331bb1282/ADVS-8-2001308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/7c4f784838e5/ADVS-8-2001308-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/554f71a8720e/ADVS-8-2001308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/4364cdb85de0/ADVS-8-2001308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/67b46c636b23/ADVS-8-2001308-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/4f0b33382ab5/ADVS-8-2001308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/ecd0936b8626/ADVS-8-2001308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/0cdac03da573/ADVS-8-2001308-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/e7d331bb1282/ADVS-8-2001308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/7c4f784838e5/ADVS-8-2001308-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/8025002/554f71a8720e/ADVS-8-2001308-g004.jpg

相似文献

1
Immunogenic Cell Death Inducing Fluorinated Mitochondria-Disrupting Helical Polypeptide Synergizes with PD-L1 Immune Checkpoint Blockade.免疫原性细胞死亡诱导的氟化破坏线粒体的螺旋多肽与 PD-L1 免疫检查点阻断协同作用。
Adv Sci (Weinh). 2021 Feb 1;8(7):2001308. doi: 10.1002/advs.202001308. eCollection 2021 Apr.
2
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.纳米胶束保护紫杉醇的免疫激活作用,并使肿瘤对抗 PD-1 免疫治疗敏感。
Theranostics. 2020 Jul 9;10(18):8382-8399. doi: 10.7150/thno.45391. eCollection 2020.
3
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment Cytotoxic T Cells.CU06-1004- 通过调节肿瘤微环境中的细胞毒性 T 细胞,诱导血管正常化可改善免疫治疗。
Front Immunol. 2021 Jan 26;11:620166. doi: 10.3389/fimmu.2020.620166. eCollection 2020.
4
Targeted delivery of anti-miRNA21 sensitizes PD-L1 tumor to immunotherapy by promoting immunogenic cell death.靶向递送抗 miRNA21 通过促进免疫原性细胞死亡使 PD-L1 肿瘤对免疫治疗敏感。
Theranostics. 2024 Jun 17;14(10):3777-3792. doi: 10.7150/thno.97755. eCollection 2024.
5
Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.多肽疫苗偶联介孔载体与免疫原性细胞死亡和 PD-L1 阻断协同作用,增强转移性脊柱肿瘤的免疫治疗。
J Nanobiotechnology. 2021 Aug 12;19(1):243. doi: 10.1186/s12951-021-00975-5.
6
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.替格来诺醇替格列酯是一种溶瘤小分子,可诱导免疫原性细胞死亡,并增强靶肿瘤和未注射肿瘤对免疫检查点阻断的反应。
J Immunother Cancer. 2024 Apr 24;12(4):e006602. doi: 10.1136/jitc-2022-006602.
7
Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.用于肿瘤免疫原性细胞死亡的顺序 pH 响应性药物递送纳米系统,并与免疫检查点阻断联合用于高效癌症化疗免疫治疗。
ACS Appl Mater Interfaces. 2021 Sep 22;13(37):43963-43974. doi: 10.1021/acsami.1c10643. Epub 2021 Sep 10.
8
Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity.小分子药物纳米组装体实现线粒体重编程,引发抗肿瘤免疫。
Nat Commun. 2024 Sep 3;15(1):7664. doi: 10.1038/s41467-024-51945-y.
9
Biosynthetic MnSe nanobomb with low Mn content activates the cGAS-STING pathway and induces immunogenic cell death to enhance antitumour immunity.生物合成的低锰含量 MnSe 纳米炸弹激活 cGAS-STING 通路,并诱导免疫原性细胞死亡,增强抗肿瘤免疫。
Acta Biomater. 2024 Aug;184:383-396. doi: 10.1016/j.actbio.2024.06.025. Epub 2024 Jun 25.
10
Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.自递送纳米增强剂增强癌症化疗免疫治疗的免疫原性细胞死亡。
ACS Appl Mater Interfaces. 2024 Jul 3;16(26):33169-33181. doi: 10.1021/acsami.4c06149. Epub 2024 Jun 24.

引用本文的文献

1
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity.靶向程序性细胞死亡:细胞凋亡、坏死性凋亡、焦亡、铁死亡和铜死亡在抗癌免疫中的作用
J Transl Int Med. 2025 Mar 19;13(1):10-32. doi: 10.1515/jtim-2025-0004. eCollection 2025 Feb.
2
Ultrasound-Targeted Microbubble Destruction Enhances the Inhibitory Effect of Sonodynamic Therapy against Hepatocellular Carcinoma.超声靶向微泡破坏增强声动力疗法对肝癌的抑制作用。
ACS Omega. 2024 Dec 18;9(52):51253-51263. doi: 10.1021/acsomega.4c07746. eCollection 2024 Dec 31.
3
Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer.

本文引用的文献

1
Development of apoptosis-inducing polypeptide via simultaneous mitochondrial membrane disruption and Ca delivery.通过同时破坏线粒体膜和钙传递诱导细胞凋亡多肽的开发。
Biomaterials. 2019 Mar;197:51-59. doi: 10.1016/j.biomaterials.2019.01.006. Epub 2019 Jan 4.
2
Immune checkpoint inhibitors: recent progress and potential biomarkers.免疫检查点抑制剂:最新进展与潜在生物标志物。
Exp Mol Med. 2018 Dec 13;50(12):1-11. doi: 10.1038/s12276-018-0191-1.
3
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
固有免疫激活与 PD-1/PD-L1 阻断联合治疗结直肠癌的细胞机制。
Mol Cancer. 2024 Nov 12;23(1):252. doi: 10.1186/s12943-024-02166-w.
4
Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy.通过代谢调控的聚合物纳米载体实现免疫原性细胞死亡的时空协调用于癌症免疫治疗。
Nat Commun. 2024 Oct 4;15(1):8586. doi: 10.1038/s41467-024-53010-0.
5
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy.靶向自噬可增强免疫检查点抑制剂对治疗耐药性的疗效:重振癌症治疗的新的有前景策略。
Heliyon. 2024 Sep 3;10(18):e37376. doi: 10.1016/j.heliyon.2024.e37376. eCollection 2024 Sep 30.
6
An immunotherapeutic hydrogel booster inhibits tumor recurrence and promotes wound healing for postoperative management of melanoma.一种免疫治疗水凝胶增强剂可抑制肿瘤复发并促进伤口愈合,用于黑色素瘤术后管理。
Bioact Mater. 2024 Aug 31;42:178-193. doi: 10.1016/j.bioactmat.2024.08.028. eCollection 2024 Dec.
7
Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironment.通过部署内源性和外源性铜以及重塑肿瘤微环境,合理设计的催化纳米平台用于增强化疗免疫治疗。
J Nanobiotechnology. 2024 Sep 9;22(1):551. doi: 10.1186/s12951-024-02696-x.
8
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy.增强癌症治疗中抗 PD-1 抗体、抗 PD-L1 抗体和抗 CTLA-4 抗体治疗效果的策略。
J Transl Med. 2024 Aug 9;22(1):751. doi: 10.1186/s12967-024-05552-6.
9
Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell-Based Therapeutics.靶向水凝胶用于基于细胞的治疗中的智能识别和时空控制。
Adv Sci (Weinh). 2024 Aug;11(30):e2404172. doi: 10.1002/advs.202404172. Epub 2024 Jun 14.
10
Lefamulin Overcomes Acquired Drug Resistance via Regulating Mitochondrial Homeostasis by Targeting ILF3 in Hepatocellular Carcinoma.左氟沙星通过靶向 ILF3 调控肝癌线粒体稳态克服获得性耐药。
Adv Sci (Weinh). 2024 Aug;11(30):e2401789. doi: 10.1002/advs.202401789. Epub 2024 Jun 14.
纳米颗粒介导的免疫原性细胞死亡使癌症免疫治疗成为可能并增强其疗效。
Angew Chem Int Ed Engl. 2019 Jan 14;58(3):670-680. doi: 10.1002/anie.201804882. Epub 2018 Nov 15.
4
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.髓源性抑制细胞阻碍免疫检查点抑制剂的抗癌活性。
Front Immunol. 2018 Jun 11;9:1310. doi: 10.3389/fimmu.2018.01310. eCollection 2018.
5
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.基于纳米盘的联合化化疗免疫疗法消除已建立的肿瘤。
Sci Adv. 2018 Apr 18;4(4):eaao1736. doi: 10.1126/sciadv.aao1736. eCollection 2018 Apr.
6
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.巨噬细胞阻碍 CD8 T 细胞到达肿瘤细胞,并限制抗 PD-1 治疗的效果。
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050. doi: 10.1073/pnas.1720948115. Epub 2018 Apr 9.
7
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.免疫原性细胞死亡通过共定位佐剂传递增强用于癌症免疫治疗。
Nano Lett. 2017 Dec 13;17(12):7387-7393. doi: 10.1021/acs.nanolett.7b03218. Epub 2017 Nov 22.
8
Conformation-switchable helical polypeptide eliciting selective pro-apoptotic activity for cancer therapy.构象可切换的螺旋多肽引发选择性促凋亡活性用于癌症治疗。
J Control Release. 2017 Oct 28;264:24-33. doi: 10.1016/j.jconrel.2017.08.001. Epub 2017 Aug 1.
9
pH-controllable cell-penetrating polypeptide that exhibits cancer targeting.具有癌症靶向性的pH可控细胞穿透多肽。
Acta Biomater. 2017 Jul 15;57:187-196. doi: 10.1016/j.actbio.2017.05.040. Epub 2017 May 17.
10
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.抗 PD-1/PD-L1 治疗复发性和/或转移性头颈部鳞状细胞癌患者中的超进展。
Ann Oncol. 2017 Jul 1;28(7):1605-1611. doi: 10.1093/annonc/mdx178.